Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $106.81 in the prior trading day, Novartis AG ADR (NYSE: NVS) closed at $107.08, up 0.25%. In other words, the price has increased by $0.25 from its previous closing price. On the day, 1.29 million shares were traded. NVS stock price reached its highest trading level at $107.09 during the session, while it also had its lowest trading level at $106.17.
Ratios:
Our goal is to gain a better understanding of NVS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.94 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.19. For the most recent quarter (mrq), Quick Ratio is recorded 0.90 and its Current Ratio is at 1.11. In the meantime, Its Debt-to-Equity ratio is 0.74 whereas as Long-Term Debt/Eq ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on September 11, 2024, Downgraded its rating to Neutral and sets its target price to $130 from $135 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 12 ’24 when Kowalski Robert William bought 6,566 shares for $111.72 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVS now has a Market Capitalization of 217322078208 and an Enterprise Value of 232513830912. As of this moment, Novartis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 12.49, and their Forward P/E ratio for the next fiscal year is 13.00. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.55. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.31 while its Price-to-Book (P/B) ratio in mrq is 4.94. Its current Enterprise Value per Revenue stands at 4.656 whereas that against EBITDA is 11.08.
Stock Price History:
Over the past 52 weeks, NVS has reached a high of $120.92, while it has fallen to a 52-week low of $92.35. The 50-Day Moving Average of the stock is -6.75%, while the 200-Day Moving Average is calculated to be 0.53%.
Shares Statistics:
The stock has traded on average 1.05M shares per day over the past 3-months and 1481460 shares per day over the last 10 days, according to various share statistics. A total of 2.04B shares are outstanding, with a floating share count of 1.96B. Insiders hold about 0.00% of the company’s shares, while institutions hold 7.07% stake in the company. Shares short for NVS as of 1728950400 were 4791122 with a Short Ratio of 4.55, compared to 1726185600 on 5323078. Therefore, it implies a Short% of Shares Outstanding of 4791122 and a Short% of Float of 0.23999999000000002.
Dividends & Splits
In the trailing 12 months, NVS’s forward annual dividend rate was 3.919, compared to 3.74 this year. Against a Trailing Annual Dividend Yield of 0.03669132The stock’s 5-year Average Dividend Yield is 3.61.
